Single Lot of Fentanyl Transdermal System 25 mcg/h Recalled by Alvogen Due to Potential for Over-Delivery
Oliver
February 7, 2025
MORRISTOWN, NJ – Consumers are advised that on January 31, 2025, Alvogen, Inc., voluntarily recalled a single lot of its Fentanyl Transdermal System 25 mcg/h transdermal patches because a defect was identified in the product’s delivery system. Fentanyl Transdermal System 25 mcg/h transdermal patches are indicated to help opioid-tolerant patients
